Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

SHREVEPORT, La. - A new drug developed by Eli Lily works in a unique way compared to treatments already on the market, like ...

SHREVEPORT, La. - A new drug developed by Eli lily works in a unique way compared to treatments already on the market, like ...

The Hunting Wives' actress Chrissy Metz gets candid in a new cover story for PEOPLE on her thoughts about using weight loss ...

The weight loss conversation has been transformed in recent years by the rise of GLP-1 medications—drugs originally developed ...

Novo Nordisk NVO faced a significant setback in July after sharply reducing its 2025 outlook for both sales and operating ...

Combining liraglutide with a very low-calorie ketogenic diet can lead to greater weight loss than the diet alone in adults ...

New research suggests popular weight loss drugs like Ozempic and Wegovy may affect more than just fat, raising questions about muscle strength and organ size after significant weight loss. University ...

Experts say the Nordic diet could rival the Mediterranean diet for weight loss and heart health. Here are the differences ...

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

Here's how to stay in a deficit safely. If you’re trying to lose weight, it’s natural to want an efficient solution. During ...

Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 ...